Inactive Instrument

United Health Products, Inc. Stock Other OTC

Equities

UEEC

US91059D1000

Medical Equipment, Supplies & Distribution

Sales 2022 37.5K Sales 2023 - Capitalization 53.85M
Net income 2022 -1M Net income 2023 -2M EV / Sales 2022 1,773 x
Net Debt 2022 674K Net Debt 2023 689K EV / Sales 2023 -
P/E ratio 2022
-38.8 x
P/E ratio 2023
-20.1 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 91.07%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 58 17-12-31
Director of Finance/CFO 45 20-11-30
Chief Operating Officer 53 18-07-31
Members of the board TitleAgeSince
Director/Board Member 53 14-11-09
Chief Executive Officer 58 17-12-31
More insiders
United Health Products, Inc. develops, manufactures, and markets hemostatic gauze for the healthcare and wound care sectors. Its gauze product, HemoStyp, is a neutralized, oxidized, regenerated cellulose (NORC) derived from cotton and designed to absorb exudate/drainage from superficial wounds and help control bleeding. Its hemostatic gauze is a collagen-like natural substance created from chemically treated cellulose derived from cotton is a flexible, silk-like material that is applied by placing the gauze onto the bleeding tissue. The material is folded to fit the size of the wound. In surface bleeding and surgical situations, the product quickly converts to a translucent gel that allows the surgeon to monitor the coagulation process. In superficial bleeding situations, HemoStyp can be bonded to an adhesive plastic bandage or integrated into a traditional gauze component to address a range of needs, including traumatic bleeding injuries and prolonged bleeding following hemodialysis.
More about the company